Avion Wealth’s Sutro Biopharma STRO Stock Holding History

Avion Wealth’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1K	Hold	72	–	–	﹤0.01%	1142
2025 Q4	$0	Hold	72	–	–	﹤0.01%	1570
2025 Q3	$0	Hold	72	–	–	﹤0.01%	1537
2025 Q2	$0	Buy	+72	New	+$589	﹤0.01%	1587

Other funds holding STRO

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Avion Wealth's STRO Position: Q1 2026 in Review

Avion Wealth held its Sutro Biopharma (STRO) position steady in Q1 2026 at 72 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Avion Wealth first reported a position in STRO in Q2 2025 and has held it in 4 quarters since. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

Avion Wealth held 72 shares of Sutro Biopharma worth $1K as of Q1 2026.
Avion Wealth left its Sutro Biopharma share count unchanged in Q1 2026.
Sutro Biopharma made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #1142 holding.
Avion Wealth first reported a position in Sutro Biopharma in Q2 2025 and has held it in 4 quarters since.
78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.